Faeth Therapeutics, Inc.
FTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829802
No open-market purchases or sales by Faeth Therapeutics, Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $333.8M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Faeth Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 43 | 1 | 40 | −2 |
| Shares | 3.55M | 2.52K | 3.11M | −436.4K (−12.3%) |
| Value | $8.21M | $6.00K | $7.06M | −$1.15M (−13.9%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Faeth Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ra Capital Management, L.P. | 723,549 | $1.64M | 0.04% |
| Newtyn Management, LLC | 415,000 | $942.0K | 0.18% |
| Ergoteles LLC | 93,598 | $212.0K | 0.01% |
| Citadel Advisors LLC | 59,380 | $134.0K | 0.00% |
| Qube Research & Technologies Ltd | 18,753 | $43.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 12,901 | $29.0K | 0.00% |
| Virtu Financial LLC | 11,223 | $25.0K | 0.00% |
| Harbour Investments, Inc. | 3 | $0 | 0.00% |
| Credit Suisse AG | 11 | $0 | 0.00% |
| Capital Advisors, Ltd. LLC | 96 | $0 | 0.00% |
| Parallel Advisors, LLC | 162 | $0 | 0.00% |
Sold out (13)
Institutions that held Faeth Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Nuveen Asset Management, LLC | 52,456 | $133.0K |
| Bank of New York Mellon Corp | 54,089 | $126.0K |
| Charles Schwab Investment Management Inc | 43,865 | $102.0K |
| Rhumbline Advisers | 16,169 | $37.0K |
| Deutsche Bank AG | 11,343 | $26.0K |
| American International Group, Inc. | 10,375 | $24.0K |
| California State Teachers Retirement System | 9,107 | $21.0K |
| FNY Investment Advisers, LLC | 3,500 | $8.00K |
| Amalgamated Bank | 2,516 | $6.00K |
| Ameritas Investment Partners, Inc. | 1,602 | $4.00K |
| Royal Bank of Canada | 1,284 | $3.00K |
| Toronto Dominion Bank | 2 | $0 |
| Ellevest, Inc. | 19 | $0 |
Not filed for Q2 2022 yet (1)
Institutions that held Faeth Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 2,516 | $6.00K |